Tomoyasu Kato

22PUBLICATIONS
141CO-AUTHORS
Epigenetics (incl. genome methylation and epigenomics)Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsCancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Aug 12, 2025
TP53 gene and pathway alterations in gastric-type adenocarcinoma of the cervix.

Daiki Higuchi, Maiko Yamaguchi, Erisa Fujii

|Jul 11, 2024
HER2-negative or low expression as an unfavorable prognostic factor in patients with stage I/II uterine carcinosarcoma.

Chiharu Mizoguchi, Tadaaki Nishikawa, Hiroshi Yoshida

|May 10, 2024
Unveiling pembrolizumab effectiveness in diverse subtypes of MSI-high endometrial cancers.

Risako Ozawa, Tadaaki Nishikawa, Hiroshi Yoshida

|Jan 05, 2024
Prevention of symptomatic pulmonary embolism for gynecologic malignancies with preoperative asymptomatic venous thromboembolism: GOTIC-VTE trial.

Yoshifumi Takahashi, Hiroyuki Fujiwara, Kouji Yamamoto

Pageof 4